Last updated: 2026-09-16 06:00:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Quest Diagnostics Inc. (DGX) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NYSE. The stock is currently priced at $247.07, with a market capitalisation of $25.94B and a P/E ratio of 24.79. Over the past 52 weeks, its price has ranged from $171.18 to $248.66. This page covers its latest market performance, valuation, price trends and company information.
$25.94B | |
$238.39 | |
$248.66 | |
$29.74 | |
$237.89 | |
1.14M | |
959.11K | |
24.79 | |
$248.66 | |
$171.18 | |
1.57% | |
-- |
Quest Diagnostics Inc. (DGX) last closed at $237.89 as of 2026-09-15 23:56:00, unchanged from the previous close of $237.89.
During the latest regular trading session, DGX traded between $29.74 and $248.66, with a volume of 1.14M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Quest Diagnostics Inc. (DGX) moved from $239.40 to $247.07, representing a gain of 3.20% ($7.67).
The stock traded between $228.57 and $248.66 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 917.79 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 98.0%
DGX is currently trading at $247.07, placing it 98.0% of the way from its 52-week low of $171.18 to its 52-week high of $248.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 57000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Quest Diagnostics Inc. (DGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.